SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3k9b'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1AV2_C_DVAC6_0 (GRAMICIDIN A)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ALA A1422 VAL A1424 TRP A1547	None	0.81A	1av2C-3k9bA: undetectable 1av2D-3k9bA: undetectable	1av2C-3k9bA: 5.88 1av2D-3k9bA: 5.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1AX9_A_EDRA999_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	GLY A1142 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.67A	1ax9A-3k9bA: 49.4	1ax9A-3k9bA: 37.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1CBS_A_REAA200_1 (CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	PHE A1178 LEU A1286 ILE A1270 ALA A1269 ALA A1265	None	1.04A	1cbsA-3k9bA: undetectable	1cbsA-3k9bA: 15.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1141 GLY A1142 GLY A1143 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None	0.42A	1dx6A-3k9bA: 52.4	1dx6A-3k9bA: 37.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FOH_C_IPHC802_0 (PHENOL HYDROXYLASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	GLY A1224 VAL A1227 ILE A1139 TYR A1170 GLY A1141	None None None None WW2 A 193 (-3.8A)	1.38A	1fohC-3k9bA: undetectable	1fohC-3k9bA: 20.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FOH_D_IPHD802_0 (PHENOL HYDROXYLASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	GLY A1224 VAL A1227 ILE A1139 TYR A1170 GLY A1141	None None None None WW2 A 193 (-3.8A)	1.40A	1fohD-3k9bA: undetectable	1fohD-3k9bA: 20.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MAA_D_DMED999_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	GLY A1142 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.32A	1maaD-3k9bA: 45.2	1maaD-3k9bA: 35.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MAA_D_DMED999_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	GLY A1143 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.97A	1maaD-3k9bA: 45.2	1maaD-3k9bA: 35.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_A_THAA1_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	10 / 11	LEU A1097 PHE A1101 GLY A1142 GLY A1143 SER A1221 VAL A1254 LEU A1255 LEU A1363 MET A1364 HIS A1468	WW2 A 193 ( 4.9A) None WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None WW2 A 193 (-3.8A) None None	0.46A	1mx1A-3k9bA: 67.2	1mx1A-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_B_THAB2_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	9 / 11	LEU A1097 PHE A1101 GLY A1142 SER A1221 VAL A1254 LEU A1358 LEU A1363 MET A1425 HIS A1468	WW2 A 193 ( 4.9A) None WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None WW2 A 193 (-3.8A) None None	0.38A	1mx1B-3k9bA: 62.1	1mx1B-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_B_THAB2_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	PHE A1101 GLY A1142 LEU A1255 LEU A1358 HIS A1468	None WW2 A 193 (-3.4A) None None None	1.29A	1mx1B-3k9bA: 62.1	1mx1B-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_C_THAC3_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1143 SER A1221 LEU A1363 PHE A1426 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-3.8A) None None	0.94A	1mx1C-3k9bA: 62.1	1mx1C-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_C_THAC3_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	10 / 12	LEU A1097 GLY A1142 SER A1221 THR A1252 VAL A1254 LEU A1255 LEU A1363 MET A1425 PHE A1426 HIS A1468	WW2 A 193 ( 4.9A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None None WW2 A 193 (-3.8A) None None None	0.45A	1mx1C-3k9bA: 62.1	1mx1C-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_D_THAD4_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	6 / 12	GLY A1143 SER A1221 ILE A1359 LEU A1363 PHE A1426 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 ( 4.3A) WW2 A 193 (-3.8A) None None	0.88A	1mx1D-3k9bA: 62.0	1mx1D-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_D_THAD4_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	10 / 12	LEU A1097 GLY A1142 GLY A1143 SER A1221 VAL A1254 LEU A1255 ILE A1359 LEU A1363 PHE A1426 HIS A1468	WW2 A 193 ( 4.9A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None WW2 A 193 ( 4.3A) WW2 A 193 (-3.8A) None None	0.51A	1mx1D-3k9bA: 62.0	1mx1D-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_D_THAD4_2 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	PHE A1101 LEU A1358 MET A1364	None	0.23A	1mx1D-3k9bA: 62.0	1mx1D-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_E_THAE5_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1143 SER A1221 MET A1364 PHE A1426 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None None	0.91A	1mx1E-3k9bA: 62.0	1mx1E-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_E_THAE5_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	10 / 12	LEU A1097 GLY A1142 VAL A1146 SER A1221 VAL A1254 MET A1364 LEU A1388 MET A1425 PHE A1426 HIS A1468	WW2 A 193 ( 4.9A) WW2 A 193 (-3.4A) None WW2 A 193 (-1.4A) None None None None None None	0.47A	1mx1E-3k9bA: 62.0	1mx1E-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1MX1_F_THAF6_1 (LIVER CARBOXYLESTERASE I)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	10 / 12	GLY A1142 GLY A1143 SER A1221 VAL A1254 LEU A1255 LEU A1363 MET A1364 MET A1425 PHE A1426 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None WW2 A 193 (-3.8A) None None None None	0.52A	1mx1F-3k9bA: 62.0	1mx1F-3k9bA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PN0_C_IPHC6032_0 (PHENOL 2-MONOOXYGENASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	GLY A1224 VAL A1227 ILE A1139 TYR A1170 GLY A1141	None None None None WW2 A 193 (-3.8A)	1.39A	1pn0C-3k9bA: undetectable	1pn0C-3k9bA: 21.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1PN0_D_IPHD6042_0 (PHENOL 2-MONOOXYGENASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	GLY A1224 VAL A1227 ILE A1139 TYR A1170 GLY A1141	None None None None WW2 A 193 (-3.8A)	1.38A	1pn0D-3k9bA: undetectable	1pn0D-3k9bA: 21.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	6 / 12	GLY A1141 GLY A1142 GLY A1143 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.51A	1qtiA-3k9bA: 51.1	1qtiA-3k9bA: 37.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUK_H_BEZH601_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	ALA A1093 LEU A1097 GLY A1147 GLY A1143	None WW2 A 193 ( 4.9A) None WW2 A 193 (-3.4A)	0.77A	1rukH-3k9bA: undetectable 1rukL-3k9bA: undetectable	1rukH-3k9bA: 17.61 1rukL-3k9bA: 18.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1W5U_C_DVAC6_0 (GRAMICIDIN D)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ALA A1422 VAL A1424 TRP A1547	None	0.75A	1w5uC-3k9bA: undetectable 1w5uD-3k9bA: undetectable	1w5uC-3k9bA: 5.88 1w5uD-3k9bA: 5.88
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1W6R_A_GNTA1536_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1141 GLY A1142 GLY A1143 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None	0.41A	1w6rA-3k9bA: 52.4	1w6rA-3k9bA: 37.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	GLY A1142 GLY A1143 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.47A	1w76A-3k9bA: 52.3	1w76A-3k9bA: 37.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	GLY A1141 GLY A1142 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.50A	1w76B-3k9bA: 51.9	1w76B-3k9bA: 37.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XVA_A_ACTA294_0 (GLYCINE N-METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 5	TRP A1500 ILE A1244 LEU A1157 ALA A1501	None	0.96A	1xvaA-3k9bA: 2.4 1xvaB-3k9bA: 2.4	1xvaA-3k9bA: 20.68 1xvaB-3k9bA: 20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XVA_B_ACTB294_0 (GLYCINE N-METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	ALA A1501 TRP A1500 ILE A1244 LEU A1157	None	1.04A	1xvaA-3k9bA: 2.4 1xvaB-3k9bA: 2.5	1xvaA-3k9bA: 20.68 1xvaB-3k9bA: 20.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_A_CTXA11_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	PRO A1360 MET A1361 LEU A1368 LEU A1418	None	0.80A	1ya4A-3k9bA: 69.0	1ya4A-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_A_CTXA11_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 8	TRP A1357 PRO A1360 LEU A1368 LEU A1418 PRO A1461	None	0.57A	1ya4A-3k9bA: 69.0	1ya4A-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_A_CTXA1_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	6 / 12	ALA A1093 GLY A1142 SER A1221 LEU A1363 MET A1364 HIS A1468	None WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-3.8A) None None	1.04A	1ya4A-3k9bA: 69.0	1ya4A-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_A_CTXA1_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	9 / 12	ALA A1093 PHE A1101 GLY A1142 GLY A1143 SER A1221 LEU A1363 MET A1364 LEU A1388 HIS A1468	None None WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-3.8A) None None None	0.38A	1ya4A-3k9bA: 69.0	1ya4A-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_B_CTXB1283_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 7	TRP A1357 PRO A1360 LEU A1368 LEU A1418 PRO A1461	None	0.53A	1ya4B-3k9bA: 61.7	1ya4B-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_B_CTXB1283_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 7	TRP A1357 PRO A1360 LYS A1414 LEU A1418 PRO A1461	None	1.37A	1ya4B-3k9bA: 61.7	1ya4B-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_B_CTXB2_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	9 / 12	PHE A1101 GLY A1142 GLY A1143 SER A1221 VAL A1254 LEU A1358 MET A1364 LEU A1388 HIS A1468	None WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None None None None	0.45A	1ya4B-3k9bA: 61.7	1ya4B-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_C_CTXC3_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	9 / 12	PHE A1101 GLY A1142 GLY A1143 SER A1221 VAL A1254 LEU A1358 MET A1364 LEU A1388 HIS A1468	None WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None None None None	0.46A	1ya4C-3k9bA: 61.6	1ya4C-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YA4_C_CTXC3_1 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	6 / 12	PHE A1101 SER A1221 SER A1365 MET A1364 LEU A1388 HIS A1468	None WW2 A 193 (-1.4A) None None None None	1.43A	1ya4C-3k9bA: 61.6	1ya4C-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_F_BEZF5023_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	GLY A1143 SER A1221 ILE A1359 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 ( 4.3A) None	0.84A	1yajF-3k9bA: 60.9	1yajF-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_F_BEZF5023_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 6	LEU A1097 GLY A1142 SER A1221 ILE A1359 HIS A1468	WW2 A 193 ( 4.9A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 ( 4.3A) None	0.37A	1yajF-3k9bA: 60.9	1yajF-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_G_BEZG3385_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	SER A1221 VAL A1254 LEU A1255	WW2 A 193 (-1.4A) None None	0.32A	1yajG-3k9bA: 64.6	1yajG-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_J_BEZJ5041_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 4	GLY A1142 SER A1221 ILE A1359 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 ( 4.3A) None	0.34A	1yajJ-3k9bA: 60.9	1yajJ-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_J_BEZJ5041_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 4	GLY A1143 SER A1221 ILE A1359 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 ( 4.3A) None	0.76A	1yajJ-3k9bA: 60.9	1yajJ-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1YAJ_K_BEZK4387_0 (CES1 PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TRP A1357 LEU A1418 LYS A1414	None	1.24A	1yajK-3k9bA: 61.0	1yajK-3k9bA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1ZWP_A_NIMA401_1 (PHOSPHOLIPASE A2 VRV-PL-VIIIA)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 5	LEU A1144 GLY A1176 TRP A1189 ASP A1193	None	1.43A	1zwpA-3k9bA: 0.0	1zwpA-3k9bA: 11.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACE_A_ACHA998_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 9	GLY A1141 GLY A1142 SER A1221 ALA A1222 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-2.9A) None	0.82A	2aceA-3k9bA: 53.5	2aceA-3k9bA: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACE_A_ACHA998_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 9	GLY A1142 GLY A1143 SER A1221 ALA A1222 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-2.9A) None	0.45A	2aceA-3k9bA: 53.5	2aceA-3k9bA: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACK_A_EDRA999_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	GLU A1354 SER A1247 PHE A1101 HIS A1468	None	1.10A	2ackA-3k9bA: 52.6	2ackA-3k9bA: 37.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2ACK_A_EDRA999_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	GLY A1142 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.70A	2ackA-3k9bA: 52.6	2ackA-3k9bA: 37.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2B25_A_SAMA601_0 (HYPOTHETICAL PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1248 GLY A1224 GLY A1141 VAL A1348 ILE A1350	None None WW2 A 193 (-3.8A) None None	1.06A	2b25A-3k9bA: undetectable	2b25A-3k9bA: 22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2BM9_B_SAMB301_0 (CEPHALOSPORIN HYDROXYLASE CMCI)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	LEU A1363 GLU A1220 GLY A1469 SER A1221 ASP A1467	WW2 A 193 (-3.8A) WW2 A 193 ( 4.2A) None WW2 A 193 (-1.4A) None	1.27A	2bm9B-3k9bA: undetectable	2bm9B-3k9bA: 18.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2DQY_C_CHDC3_0 (LIVER CARBOXYLESTERASE 1)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 6	TRP A1357 LEU A1368 LEU A1418 PRO A1461 VAL A1464	None	0.42A	2dqyC-3k9bA: 61.6	2dqyC-3k9bA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HA4_A_ACHA546_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	TYR A1152 GLU A1220 HIS A1468 GLY A1469	None WW2 A 193 ( 4.2A) None None	0.40A	2ha4A-3k9bA: 46.7	2ha4A-3k9bA: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HA4_A_ACTA544_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	GLY A1142 GLY A1143 ALA A1222 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-2.9A) None	0.29A	2ha4A-3k9bA: 46.7	2ha4A-3k9bA: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HA4_B_ACHB603_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	TYR A1152 GLU A1220 HIS A1468 GLY A1469	None WW2 A 193 ( 4.2A) None None	0.34A	2ha4B-3k9bA: 52.1	2ha4B-3k9bA: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	GLY A1141 GLY A1142 ALA A1222 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-2.9A) None	0.68A	2ha4B-3k9bA: 52.1	2ha4B-3k9bA: 35.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2HA4_B_ACTB601_0 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	GLY A1142 GLY A1143 ALA A1222 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-2.9A) None	0.29A	2ha4B-3k9bA: 52.1	2ha4B-3k9bA: 35.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IZQ_B_DVAB6_0 (GRAMICIDIN D)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TRP A1547 ALA A1422 VAL A1424	None	0.77A	2izqA-3k9bA: undetectable 2izqB-3k9bA: undetectable	2izqA-3k9bA: 5.88 2izqB-3k9bA: 5.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OGY_A_C2FA3000_0 (5-METHYLTETRAHYDROFO LATE CORRINOID/IRON SULFUR PROTEIN METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLU A1220 PHE A1101 ILE A1217 LEU A1230 GLY A1224	WW2 A 193 ( 4.2A) None None None None	1.32A	2ogyA-3k9bA: 2.1	2ogyA-3k9bA: 18.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OXT_B_SAMB300_0 (NUCLEOSIDE-2'-O-METH YLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1190 GLY A1143 GLY A1173 LEU A1097 HIS A1468	None WW2 A 193 (-3.4A) None WW2 A 193 ( 4.9A) None	0.81A	2oxtB-3k9bA: undetectable	2oxtB-3k9bA: 19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PYN_A_1UNA1001_3 (PROTEASE RETROPEPSIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1260 THR A1331 PRO A1332	None	0.58A	2pynB-3k9bA: undetectable	2pynB-3k9bA: 11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2Q64_B_1UNB1001_4 (PROTEASE RETROPEPSIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1260 THR A1331 PRO A1332	None	0.64A	2q64B-3k9bA: undetectable	2q64B-3k9bA: 11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QAK_A_1UNA1001_4 (PROTEASE RETROPEPSIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1260 THR A1331 PRO A1332	None	0.58A	2qakB-3k9bA: undetectable	2qakB-3k9bA: 11.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0M_A_KLNA1500_1 (CYTOCHROME P450 3A4)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	LEU A1117 ILE A1168 ALA A1149 GLU A1225 LEU A1172	None	1.33A	2v0mA-3k9bA: undetectable	2v0mA-3k9bA: 25.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BXO_A_SAMA238_1 (N,N-DIMETHYLTRANSFER ASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TYR A1170 GLU A1220 ASP A1467	None WW2 A 193 ( 4.2A) None	0.77A	3bxoA-3k9bA: undetectable	3bxoA-3k9bA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BXO_A_SAMA238_1 (N,N-DIMETHYLTRANSFER ASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TYR A1170 GLU A1220 ASP A1470	None WW2 A 193 ( 4.2A) None	0.79A	3bxoA-3k9bA: undetectable	3bxoA-3k9bA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BXO_B_SAMB238_1 (N,N-DIMETHYLTRANSFER ASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TYR A1170 GLU A1220 ASP A1467	None WW2 A 193 ( 4.2A) None	0.84A	3bxoB-3k9bA: undetectable	3bxoB-3k9bA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3BXO_B_SAMB238_1 (N,N-DIMETHYLTRANSFER ASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	TYR A1170 GLU A1220 ASP A1470	None WW2 A 193 ( 4.2A) None	0.78A	3bxoB-3k9bA: undetectable	3bxoB-3k9bA: 19.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3DL9_B_V2HB602_0 (CYTOCHROME P450 2R1)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	THR A1321 VAL A1231 ALA A1236 GLU A1225 ILE A1139	None	1.07A	3dl9B-3k9bA: undetectable	3dl9B-3k9bA: 22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H52_B_486B1_1 (GLUCOCORTICOID RECEPTOR)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 10	ASN A1351 TRP A1500 GLN A1528 LEU A1527 TYR A1526	None	1.31A	3h52B-3k9bA: 0.0	3h52B-3k9bA: 21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KU1_A_SAMA226_0 (SAM-DEPENDENT METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	LEU A1472 GLY A1224 VAL A1229 GLY A1141 LEU A1144	None None None WW2 A 193 (-3.8A) None	0.95A	3ku1A-3k9bA: 2.9	3ku1A-3k9bA: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3KU1_C_SAMC226_0 (SAM-DEPENDENT METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	LEU A1472 GLY A1224 VAL A1229 GLY A1141 LEU A1144	None None None WW2 A 193 (-3.8A) None	0.95A	3ku1C-3k9bA: 2.8	3ku1C-3k9bA: 19.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L8L_A_DVAA6_0 (GRAMICIDIN D)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ALA A1422 VAL A1424 TRP A1547	None	0.75A	3l8lA-3k9bA: undetectable 3l8lB-3k9bA: undetectable	3l8lA-3k9bA: 5.88 3l8lB-3k9bA: 3.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3L8L_C_DVAC6_0 (GRAMICIDIN D)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ALA A1422 VAL A1424 TRP A1547	None	0.67A	3l8lC-3k9bA: undetectable 3l8lD-3k9bA: undetectable	3l8lC-3k9bA: 5.88 3l8lD-3k9bA: 3.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O9M_A_BEZA999_0 (CHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 7	GLY A1141 GLY A1142 SER A1221 LEU A1363 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-3.8A) None	1.18A	3o9mA-3k9bA: 53.3	3o9mA-3k9bA: 36.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O9M_A_BEZA999_0 (CHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 7	GLY A1142 GLY A1143 SER A1221 PHE A1426 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None None	0.74A	3o9mA-3k9bA: 53.3	3o9mA-3k9bA: 36.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O9M_B_BEZB999_0 (CHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 6	GLY A1141 GLY A1142 SER A1221 LEU A1363 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) WW2 A 193 (-3.8A) None	1.17A	3o9mB-3k9bA: 53.3	3o9mB-3k9bA: 36.58
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3O9M_B_BEZB999_0 (CHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	GLY A1142 GLY A1143 SER A1221 HIS A1468	WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None	0.42A	3o9mB-3k9bA: 53.3	3o9mB-3k9bA: 36.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PS9_A_SAMA670_1 (TRNA 5-METHYLAMINOMETHYL- 2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	GLY A1469 LEU A1100 GLU A1471 ASP A1467	None	0.96A	3ps9A-3k9bA: undetectable	3ps9A-3k9bA: 22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SU9_A_ACTA426_0 (UDP-N-ACETYLGLUCOSAM INE 1-CARBOXYVINYLTRANSF ERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	GLN A1069 GLU A1072 LYS A1057	None	1.08A	3su9A-3k9bA: undetectable	3su9A-3k9bA: 23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TKG_C_ROCC901_3 (PROTEASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1260 THR A1331 PRO A1332	None	0.65A	3tkgD-3k9bA: undetectable	3tkgD-3k9bA: 11.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4AC9_C_DXCC1478_0 (MJ0495-LIKE PROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 7	SER A1179 GLY A1320 THR A1321 SER A1185	None	0.77A	4ac9C-3k9bA: 2.7	4ac9C-3k9bA: 20.53
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1141 GLY A1142 GLY A1143 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 (-1.4A) None	0.39A	4ey6A-3k9bA: 51.7	4ey6A-3k9bA: 36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	6 / 12	GLY A1141 GLY A1142 GLY A1143 GLU A1220 SER A1221 HIS A1468	WW2 A 193 (-3.8A) WW2 A 193 (-3.4A) WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None	0.53A	4ey6B-3k9bA: 45.5	4ey6B-3k9bA: 36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY7_A_E20A604_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	GLY A1141 GLU A1220 SER A1221 HIS A1468 GLY A1469	WW2 A 193 (-3.8A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None None	1.13A	4ey7A-3k9bA: 51.6	4ey7A-3k9bA: 36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY7_A_E20A604_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	GLY A1142 GLU A1220 SER A1221 HIS A1468 GLY A1469	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None None	0.66A	4ey7A-3k9bA: 51.6	4ey7A-3k9bA: 36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY7_B_E20B605_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	GLY A1141 GLU A1220 SER A1221 HIS A1468 GLY A1469	WW2 A 193 (-3.8A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None None	1.14A	4ey7B-3k9bA: 46.7	4ey7B-3k9bA: 36.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4EY7_B_E20B605_1 (ACETYLCHOLINESTERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	GLY A1142 GLU A1220 SER A1221 HIS A1468 GLY A1469	WW2 A 193 (-3.4A) WW2 A 193 ( 4.2A) WW2 A 193 (-1.4A) None None	0.69A	4ey7B-3k9bA: 46.7	4ey7B-3k9bA: 36.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FGL_A_CLQA303_0 (RIBOSYLDIHYDRONICOTI NAMIDE DEHYDROGENASE [QUINONE])	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1209 GLY A1210 VAL A1047 PHE A1050 ILE A1121	None	1.26A	4fglA-3k9bA: 2.5 4fglB-3k9bA: 2.4	4fglA-3k9bA: 19.96 4fglB-3k9bA: 19.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PTJ_A_FOLA201_1 (DIHYDROFOLATE REDUCTASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1260 LYS A1257 LEU A1319	None	1.05A	4ptjA-3k9bA: 1.4	4ptjA-3k9bA: 14.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_C_377C401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	TYR A1152 ASN A1103 GLU A1246 LEU A1157	None	1.01A	4twdB-3k9bA: undetectable 4twdC-3k9bA: undetectable	4twdB-3k9bA: 19.89 4twdC-3k9bA: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_E_377E401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	TYR A1152 ASN A1103 GLU A1246 LEU A1157	None	0.98A	4twdD-3k9bA: undetectable 4twdE-3k9bA: undetectable	4twdD-3k9bA: 19.89 4twdE-3k9bA: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4TWD_J_377J401_1 (CYS-LOOP LIGAND-GATED ION CHANNEL)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 6	TYR A1152 ASN A1103 GLU A1246 LEU A1157	None	0.93A	4twdI-3k9bA: undetectable 4twdJ-3k9bA: undetectable	4twdI-3k9bA: 19.89 4twdJ-3k9bA: 19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4WNU_C_QDNC602_1 (CYTOCHROME P450 2D6)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 11	LEU A1230 GLY A1223 GLU A1225 ALA A1243 SER A1245	None	1.12A	4wnuC-3k9bA: undetectable	4wnuC-3k9bA: 22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4XLD_A_BRLA502_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	PHE A1101 GLY A1147 LEU A1255 HIS A1468 LEU A1363	None None None None WW2 A 193 (-3.8A)	1.40A	4xldA-3k9bA: undetectable	4xldA-3k9bA: 19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZJQ_D_ERYD1101_0 (MULTIDRUG EFFLUX PUMP SUBUNIT ACRB)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	THR A1321 SER A1228 MET A1446 ILE A1350 GLU A1333	None	1.45A	4zjqD-3k9bA: undetectable	4zjqD-3k9bA: 20.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HBS_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 8	LEU A1110 LEU A1051 THR A1167 TYR A1152	None	1.03A	5hbsA-3k9bA: undetectable	5hbsA-3k9bA: 13.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5JGL_B_SAMB301_1 (UBIE/COQ5 FAMILY METHYLTRANSFERASE, PUTATIVE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	ASP A1027 ASN A1204 PHE A1076	None	0.76A	5jglB-3k9bA: undetectable	5jglB-3k9bA: 20.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KQS_A_SAMA307_0 (GENOME POLYPROTEIN)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1248 GLY A1143 GLY A1141 GLY A1224 ASP A1090	None WW2 A 193 (-3.4A) WW2 A 193 (-3.8A) None None	0.89A	5kqsA-3k9bA: undetectable	5kqsA-3k9bA: 20.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5M5B_A_SAMA1001_0 (NS5 METHYLTRANSFERASE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	GLY A1248 GLY A1143 GLY A1141 GLY A1224 ASP A1090	None WW2 A 193 (-3.4A) WW2 A 193 (-3.8A) None None	0.89A	5m5bA-3k9bA: undetectable	5m5bA-3k9bA: 19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5NWV_A_ACAA18_1 (SCRFP-TAG,GP41)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	5 / 12	SER A1113 LYS A1111 GLU A1296 LEU A1295 GLU A1114	None	1.33A	5nwvA-3k9bA: undetectable	5nwvA-3k9bA: 7.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XIP_A_HFGA1003_1 (PROLYL-TRNA SYNTHETASE, PUTATIVE)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	3 / 3	GLU A1471 TRP A1138 HIS A1468	None	1.07A	5xipA-3k9bA: undetectable	5xipA-3k9bA: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6JI6_A_ACTA305_0 (GLUTATHIONE S-TRANSFERASE CLASS-MU 26 KDA ISOZYME)	3k9b	LIVER CARBOXYLESTERASE 1 (Homo sapiens)	4 / 5	GLY A1052 LEU A1051 SER A1150 GLN A1169	None	1.14A	6ji6A-3k9bA: undetectable	6ji6A-3k9bA: 17.92

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1AV2_C_DVAC6_0","GRAMICIDIN A","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ALA A1422;VAL A1424;TRP A1547","None","0.81A","1av2C-3k9bA:undetectable;1av2D-3k9bA:undetectable","1av2C-3k9bA:5.88;1av2D-3k9bA:5.88"],["1AX9_A_EDRA999_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.67A","1ax9A-3k9bA:49.4","1ax9A-3k9bA:37.06"],["1CBS_A_REAA200_1","CELLULAR RETINOIC ACID BINDING PROTEIN TYPE II","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"PHE A1178;LEU A1286;ILE A1270;ALA A1269;ALA A1265","None","1.04A","1cbsA-3k9bA:undetectable","1cbsA-3k9bA:15.80"],["1DX6_A_GNTA602_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;GLY A1143;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None","0.42A","1dx6A-3k9bA:52.4","1dx6A-3k9bA:37.19"],["1FOH_C_IPHC802_0","PHENOL HYDROXYLASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1224;VAL A1227;ILE A1139;TYR A1170;GLY A1141","None;None;None;None;WW2 A 193 (-3.8A)","1.38A","1fohC-3k9bA:undetectable","1fohC-3k9bA:20.91"],["1FOH_D_IPHD802_0","PHENOL HYDROXYLASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1224;VAL A1227;ILE A1139;TYR A1170;GLY A1141","None;None;None;None;WW2 A 193 (-3.8A)","1.40A","1fohD-3k9bA:undetectable","1fohD-3k9bA:20.91"],["1MAA_D_DMED999_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.32A","1maaD-3k9bA:45.2","1maaD-3k9bA:35.71"],["1MAA_D_DMED999_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1143;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.97A","1maaD-3k9bA:45.2","1maaD-3k9bA:35.71"],["1MX1_A_THAA1_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",10,"LEU A1097;PHE A1101;GLY A1142;GLY A1143;SER A1221;VAL A1254;LEU A1255;LEU A1363;MET A1364;HIS A1468","WW2 A 193 ( 4.9A);None;WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;WW2 A 193 (-3.8A);None;None","0.46A","1mx1A-3k9bA:67.2","1mx1A-3k9bA:100.00"],["1MX1_B_THAB2_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",9,"LEU A1097;PHE A1101;GLY A1142;SER A1221;VAL A1254;LEU A1358;LEU A1363;MET A1425;HIS A1468","WW2 A 193 ( 4.9A);None;WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;WW2 A 193 (-3.8A);None;None","0.38A","1mx1B-3k9bA:62.1","1mx1B-3k9bA:100.00"],["1MX1_B_THAB2_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"PHE A1101;GLY A1142;LEU A1255;LEU A1358;HIS A1468","None;WW2 A 193 (-3.4A);None;None;None","1.29A","1mx1B-3k9bA:62.1","1mx1B-3k9bA:100.00"],["1MX1_C_THAC3_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1143;SER A1221;LEU A1363;PHE A1426;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-3.8A);None;None","0.94A","1mx1C-3k9bA:62.1","1mx1C-3k9bA:100.00"],["1MX1_C_THAC3_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",10,"LEU A1097;GLY A1142;SER A1221;THR A1252;VAL A1254;LEU A1255;LEU A1363;MET A1425;PHE A1426;HIS A1468","WW2 A 193 ( 4.9A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;None;WW2 A 193 (-3.8A);None;None;None","0.45A","1mx1C-3k9bA:62.1","1mx1C-3k9bA:100.00"],["1MX1_D_THAD4_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",6,"GLY A1143;SER A1221;ILE A1359;LEU A1363;PHE A1426;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 ( 4.3A);WW2 A 193 (-3.8A);None;None","0.88A","1mx1D-3k9bA:62.0","1mx1D-3k9bA:100.00"],["1MX1_D_THAD4_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",10,"LEU A1097;GLY A1142;GLY A1143;SER A1221;VAL A1254;LEU A1255;ILE A1359;LEU A1363;PHE A1426;HIS A1468","WW2 A 193 ( 4.9A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;WW2 A 193 ( 4.3A);WW2 A 193 (-3.8A);None;None","0.51A","1mx1D-3k9bA:62.0","1mx1D-3k9bA:100.00"],["1MX1_D_THAD4_2","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"PHE A1101;LEU A1358;MET A1364","None","0.23A","1mx1D-3k9bA:62.0","1mx1D-3k9bA:100.00"],["1MX1_E_THAE5_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1143;SER A1221;MET A1364;PHE A1426;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;None","0.91A","1mx1E-3k9bA:62.0","1mx1E-3k9bA:100.00"],["1MX1_E_THAE5_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",10,"LEU A1097;GLY A1142;VAL A1146;SER A1221;VAL A1254;MET A1364;LEU A1388;MET A1425;PHE A1426;HIS A1468","WW2 A 193 ( 4.9A);WW2 A 193 (-3.4A);None;WW2 A 193 (-1.4A);None;None;None;None;None;None","0.47A","1mx1E-3k9bA:62.0","1mx1E-3k9bA:100.00"],["1MX1_F_THAF6_1","LIVER CARBOXYLESTERASE I","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",10,"GLY A1142;GLY A1143;SER A1221;VAL A1254;LEU A1255;LEU A1363;MET A1364;MET A1425;PHE A1426;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;WW2 A 193 (-3.8A);None;None;None;None","0.52A","1mx1F-3k9bA:62.0","1mx1F-3k9bA:100.00"],["1PN0_C_IPHC6032_0","PHENOL 2-MONOOXYGENASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1224;VAL A1227;ILE A1139;TYR A1170;GLY A1141","None;None;None;None;WW2 A 193 (-3.8A)","1.39A","1pn0C-3k9bA:undetectable","1pn0C-3k9bA:21.11"],["1PN0_D_IPHD6042_0","PHENOL 2-MONOOXYGENASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1224;VAL A1227;ILE A1139;TYR A1170;GLY A1141","None;None;None;None;WW2 A 193 (-3.8A)","1.38A","1pn0D-3k9bA:undetectable","1pn0D-3k9bA:21.11"],["1QTI_A_GNTA600_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",6,"GLY A1141;GLY A1142;GLY A1143;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.51A","1qtiA-3k9bA:51.1","1qtiA-3k9bA:37.06"],["1RUK_H_BEZH601_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"ALA A1093;LEU A1097;GLY A1147;GLY A1143","None;WW2 A 193 ( 4.9A);None;WW2 A 193 (-3.4A)","0.77A","1rukH-3k9bA:undetectable;1rukL-3k9bA:undetectable","1rukH-3k9bA:17.61;1rukL-3k9bA:18.27"],["1W5U_C_DVAC6_0","GRAMICIDIN D","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ALA A1422;VAL A1424;TRP A1547","None","0.75A","1w5uC-3k9bA:undetectable;1w5uD-3k9bA:undetectable","1w5uC-3k9bA:5.88;1w5uD-3k9bA:5.88"],["1W6R_A_GNTA1536_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;GLY A1143;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None","0.41A","1w6rA-3k9bA:52.4","1w6rA-3k9bA:37.19"],["1W76_A_GNTA1538_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1142;GLY A1143;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.47A","1w76A-3k9bA:52.3","1w76A-3k9bA:37.19"],["1W76_B_GNTB1538_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.50A","1w76B-3k9bA:51.9","1w76B-3k9bA:37.19"],["1XVA_A_ACTA294_0","GLYCINE N-METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TRP A1500;ILE A1244;LEU A1157;ALA A1501","None","0.96A","1xvaA-3k9bA:2.4;1xvaB-3k9bA:2.4","1xvaA-3k9bA:20.68;1xvaB-3k9bA:20.68"],["1XVA_B_ACTB294_0","GLYCINE N-METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"ALA A1501;TRP A1500;ILE A1244;LEU A1157","None","1.04A","1xvaA-3k9bA:2.4;1xvaB-3k9bA:2.5","1xvaA-3k9bA:20.68;1xvaB-3k9bA:20.68"],["1YA4_A_CTXA11_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"PRO A1360;MET A1361;LEU A1368;LEU A1418","None","0.80A","1ya4A-3k9bA:69.0","1ya4A-3k9bA:100.00"],["1YA4_A_CTXA11_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"TRP A1357;PRO A1360;LEU A1368;LEU A1418;PRO A1461","None","0.57A","1ya4A-3k9bA:69.0","1ya4A-3k9bA:100.00"],["1YA4_A_CTXA1_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",6,"ALA A1093;GLY A1142;SER A1221;LEU A1363;MET A1364;HIS A1468","None;WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-3.8A);None;None","1.04A","1ya4A-3k9bA:69.0","1ya4A-3k9bA:100.00"],["1YA4_A_CTXA1_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",9,"ALA A1093;PHE A1101;GLY A1142;GLY A1143;SER A1221;LEU A1363;MET A1364;LEU A1388;HIS A1468","None;None;WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-3.8A);None;None;None","0.38A","1ya4A-3k9bA:69.0","1ya4A-3k9bA:100.00"],["1YA4_B_CTXB1283_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"TRP A1357;PRO A1360;LEU A1368;LEU A1418;PRO A1461","None","0.53A","1ya4B-3k9bA:61.7","1ya4B-3k9bA:100.00"],["1YA4_B_CTXB1283_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"TRP A1357;PRO A1360;LYS A1414;LEU A1418;PRO A1461","None","1.37A","1ya4B-3k9bA:61.7","1ya4B-3k9bA:100.00"],["1YA4_B_CTXB2_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",9,"PHE A1101;GLY A1142;GLY A1143;SER A1221;VAL A1254;LEU A1358;MET A1364;LEU A1388;HIS A1468","None;WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;None;None;None","0.45A","1ya4B-3k9bA:61.7","1ya4B-3k9bA:100.00"],["1YA4_C_CTXC3_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",9,"PHE A1101;GLY A1142;GLY A1143;SER A1221;VAL A1254;LEU A1358;MET A1364;LEU A1388;HIS A1468","None;WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None;None;None;None","0.46A","1ya4C-3k9bA:61.6","1ya4C-3k9bA:100.00"],["1YA4_C_CTXC3_1","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",6,"PHE A1101;SER A1221;SER A1365;MET A1364;LEU A1388;HIS A1468","None;WW2 A 193 (-1.4A);None;None;None;None","1.43A","1ya4C-3k9bA:61.6","1ya4C-3k9bA:100.00"],["1YAJ_F_BEZF5023_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1143;SER A1221;ILE A1359;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 ( 4.3A);None","0.84A","1yajF-3k9bA:60.9","1yajF-3k9bA:100.00"],["1YAJ_F_BEZF5023_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1097;GLY A1142;SER A1221;ILE A1359;HIS A1468","WW2 A 193 ( 4.9A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 ( 4.3A);None","0.37A","1yajF-3k9bA:60.9","1yajF-3k9bA:100.00"],["1YAJ_G_BEZG3385_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"SER A1221;VAL A1254;LEU A1255","WW2 A 193 (-1.4A);None;None","0.32A","1yajG-3k9bA:64.6","1yajG-3k9bA:100.00"],["1YAJ_J_BEZJ5041_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;SER A1221;ILE A1359;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 ( 4.3A);None","0.34A","1yajJ-3k9bA:60.9","1yajJ-3k9bA:100.00"],["1YAJ_J_BEZJ5041_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1143;SER A1221;ILE A1359;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 ( 4.3A);None","0.76A","1yajJ-3k9bA:60.9","1yajJ-3k9bA:100.00"],["1YAJ_K_BEZK4387_0","CES1 PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TRP A1357;LEU A1418;LYS A1414","None","1.24A","1yajK-3k9bA:61.0","1yajK-3k9bA:100.00"],["1ZWP_A_NIMA401_1","PHOSPHOLIPASE A2 VRV-PL-VIIIA","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"LEU A1144;GLY A1176;TRP A1189;ASP A1193","None","1.43A","1zwpA-3k9bA:0.0","1zwpA-3k9bA:11.73"],["2ACE_A_ACHA998_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;SER A1221;ALA A1222;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-2.9A);None","0.82A","2aceA-3k9bA:53.5","2aceA-3k9bA:37.06"],["2ACE_A_ACHA998_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1142;GLY A1143;SER A1221;ALA A1222;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-2.9A);None","0.45A","2aceA-3k9bA:53.5","2aceA-3k9bA:37.06"],["2ACK_A_EDRA999_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLU A1354;SER A1247;PHE A1101;HIS A1468","None","1.10A","2ackA-3k9bA:52.6","2ackA-3k9bA:37.06"],["2ACK_A_EDRA999_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.70A","2ackA-3k9bA:52.6","2ackA-3k9bA:37.06"],["2B25_A_SAMA601_0","HYPOTHETICAL PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1248;GLY A1224;GLY A1141;VAL A1348;ILE A1350","None;None;WW2 A 193 (-3.8A);None;None","1.06A","2b25A-3k9bA:undetectable","2b25A-3k9bA:22.20"],["2BM9_B_SAMB301_0","CEPHALOSPORIN HYDROXYLASE CMCI","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1363;GLU A1220;GLY A1469;SER A1221;ASP A1467","WW2 A 193 (-3.8A);WW2 A 193 ( 4.2A);None;WW2 A 193 (-1.4A);None","1.27A","2bm9B-3k9bA:undetectable","2bm9B-3k9bA:18.65"],["2DQY_C_CHDC3_0","LIVER CARBOXYLESTERASE 1","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"TRP A1357;LEU A1368;LEU A1418;PRO A1461;VAL A1464","None","0.42A","2dqyC-3k9bA:61.6","2dqyC-3k9bA:100.00"],["2HA4_A_ACHA546_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TYR A1152;GLU A1220;HIS A1468;GLY A1469","None;WW2 A 193 ( 4.2A);None;None","0.40A","2ha4A-3k9bA:46.7","2ha4A-3k9bA:35.54"],["2HA4_A_ACTA544_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLY A1143;ALA A1222;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-2.9A);None","0.29A","2ha4A-3k9bA:46.7","2ha4A-3k9bA:35.54"],["2HA4_B_ACHB603_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TYR A1152;GLU A1220;HIS A1468;GLY A1469","None;WW2 A 193 ( 4.2A);None;None","0.34A","2ha4B-3k9bA:52.1","2ha4B-3k9bA:35.54"],["2HA4_B_ACTB601_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1141;GLY A1142;ALA A1222;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-2.9A);None","0.68A","2ha4B-3k9bA:52.1","2ha4B-3k9bA:35.54"],["2HA4_B_ACTB601_0","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLY A1143;ALA A1222;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-2.9A);None","0.29A","2ha4B-3k9bA:52.1","2ha4B-3k9bA:35.54"],["2IZQ_B_DVAB6_0","GRAMICIDIN D","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TRP A1547;ALA A1422;VAL A1424","None","0.77A","2izqA-3k9bA:undetectable;2izqB-3k9bA:undetectable","2izqA-3k9bA:5.88;2izqB-3k9bA:5.88"],["2OGY_A_C2FA3000_0","5-METHYLTETRAHYDROFOLATE CORRINOID\/IRON SULFUR PROTEIN METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLU A1220;PHE A1101;ILE A1217;LEU A1230;GLY A1224","WW2 A 193 ( 4.2A);None;None;None;None","1.32A","2ogyA-3k9bA:2.1","2ogyA-3k9bA:18.05"],["2OXT_B_SAMB300_0","NUCLEOSIDE-2'-O-METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1190;GLY A1143;GLY A1173;LEU A1097;HIS A1468","None;WW2 A 193 (-3.4A);None;WW2 A 193 ( 4.9A);None","0.81A","2oxtB-3k9bA:undetectable","2oxtB-3k9bA:19.93"],["2PYN_A_1UNA1001_3","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1260;THR A1331;PRO A1332","None","0.58A","2pynB-3k9bA:undetectable","2pynB-3k9bA:11.20"],["2Q64_B_1UNB1001_4","PROTEASE RETROPEPSIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1260;THR A1331;PRO A1332","None","0.64A","2q64B-3k9bA:undetectable","2q64B-3k9bA:11.20"],["2QAK_A_1UNA1001_4","PROTEASE RETROPEPSIN;PROTEASE RETROPEPSIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1260;THR A1331;PRO A1332","None","0.58A","2qakB-3k9bA:undetectable","2qakB-3k9bA:11.20"],["2V0M_A_KLNA1500_1","CYTOCHROME P450 3A4","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1117;ILE A1168;ALA A1149;GLU A1225;LEU A1172","None","1.33A","2v0mA-3k9bA:undetectable","2v0mA-3k9bA:25.08"],["3BXO_A_SAMA238_1","N,N-DIMETHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TYR A1170;GLU A1220;ASP A1467","None;WW2 A 193 ( 4.2A);None","0.77A","3bxoA-3k9bA:undetectable","3bxoA-3k9bA:19.74"],["3BXO_A_SAMA238_1","N,N-DIMETHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TYR A1170;GLU A1220;ASP A1470","None;WW2 A 193 ( 4.2A);None","0.79A","3bxoA-3k9bA:undetectable","3bxoA-3k9bA:19.74"],["3BXO_B_SAMB238_1","N,N-DIMETHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TYR A1170;GLU A1220;ASP A1467","None;WW2 A 193 ( 4.2A);None","0.84A","3bxoB-3k9bA:undetectable","3bxoB-3k9bA:19.74"],["3BXO_B_SAMB238_1","N,N-DIMETHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"TYR A1170;GLU A1220;ASP A1470","None;WW2 A 193 ( 4.2A);None","0.78A","3bxoB-3k9bA:undetectable","3bxoB-3k9bA:19.74"],["3DL9_B_V2HB602_0","CYTOCHROME P450 2R1","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"THR A1321;VAL A1231;ALA A1236;GLU A1225;ILE A1139","None","1.07A","3dl9B-3k9bA:undetectable","3dl9B-3k9bA:22.14"],["3H52_B_486B1_1","GLUCOCORTICOID RECEPTOR","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"ASN A1351;TRP A1500;GLN A1528;LEU A1527;TYR A1526","None","1.31A","3h52B-3k9bA:0.0","3h52B-3k9bA:21.61"],["3KU1_A_SAMA226_0","SAM-DEPENDENT METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1472;GLY A1224;VAL A1229;GLY A1141;LEU A1144","None;None;None;WW2 A 193 (-3.8A);None","0.95A","3ku1A-3k9bA:2.9","3ku1A-3k9bA:19.14"],["3KU1_C_SAMC226_0","SAM-DEPENDENT METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1472;GLY A1224;VAL A1229;GLY A1141;LEU A1144","None;None;None;WW2 A 193 (-3.8A);None","0.95A","3ku1C-3k9bA:2.8","3ku1C-3k9bA:19.14"],["3L8L_A_DVAA6_0","GRAMICIDIN D","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ALA A1422;VAL A1424;TRP A1547","None","0.75A","3l8lA-3k9bA:undetectable;3l8lB-3k9bA:undetectable","3l8lA-3k9bA:5.88;3l8lB-3k9bA:3.48"],["3L8L_C_DVAC6_0","GRAMICIDIN D","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ALA A1422;VAL A1424;TRP A1547","None","0.67A","3l8lC-3k9bA:undetectable;3l8lD-3k9bA:undetectable","3l8lC-3k9bA:5.88;3l8lD-3k9bA:3.48"],["3O9M_A_BEZA999_0","CHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;SER A1221;LEU A1363;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-3.8A);None","1.18A","3o9mA-3k9bA:53.3","3o9mA-3k9bA:36.58"],["3O9M_A_BEZA999_0","CHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1142;GLY A1143;SER A1221;PHE A1426;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None;None","0.74A","3o9mA-3k9bA:53.3","3o9mA-3k9bA:36.58"],["3O9M_B_BEZB999_0","CHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;SER A1221;LEU A1363;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);WW2 A 193 (-3.8A);None","1.17A","3o9mB-3k9bA:53.3","3o9mB-3k9bA:36.58"],["3O9M_B_BEZB999_0","CHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1142;GLY A1143;SER A1221;HIS A1468","WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None","0.42A","3o9mB-3k9bA:53.3","3o9mB-3k9bA:36.58"],["3PS9_A_SAMA670_1","TRNA 5-METHYLAMINOMETHYL-2-THIOURIDINE BIOSYNTHESIS BIFUNCTIONAL PROTEIN MNMC","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1469;LEU A1100;GLU A1471;ASP A1467","None","0.96A","3ps9A-3k9bA:undetectable","3ps9A-3k9bA:22.56"],["3SU9_A_ACTA426_0","UDP-N-ACETYLGLUCOSAMINE 1-CARBOXYVINYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"GLN A1069;GLU A1072;LYS A1057","None","1.08A","3su9A-3k9bA:undetectable","3su9A-3k9bA:23.27"],["3TKG_C_ROCC901_3","PROTEASE;PROTEASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1260;THR A1331;PRO A1332","None","0.65A","3tkgD-3k9bA:undetectable","3tkgD-3k9bA:11.39"],["4AC9_C_DXCC1478_0","MJ0495-LIKE PROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"SER A1179;GLY A1320;THR A1321;SER A1185","None","0.77A","4ac9C-3k9bA:2.7","4ac9C-3k9bA:20.53"],["4EY6_A_GNTA604_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLY A1142;GLY A1143;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 (-1.4A);None","0.39A","4ey6A-3k9bA:51.7","4ey6A-3k9bA:36.13"],["4EY6_B_GNTB605_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",6,"GLY A1141;GLY A1142;GLY A1143;GLU A1220;SER A1221;HIS A1468","WW2 A 193 (-3.8A);WW2 A 193 (-3.4A);WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None","0.53A","4ey6B-3k9bA:45.5","4ey6B-3k9bA:36.13"],["4EY7_A_E20A604_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLU A1220;SER A1221;HIS A1468;GLY A1469","WW2 A 193 (-3.8A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None;None","1.13A","4ey7A-3k9bA:51.6","4ey7A-3k9bA:36.13"],["4EY7_A_E20A604_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1142;GLU A1220;SER A1221;HIS A1468;GLY A1469","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None;None","0.66A","4ey7A-3k9bA:51.6","4ey7A-3k9bA:36.13"],["4EY7_B_E20B605_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1141;GLU A1220;SER A1221;HIS A1468;GLY A1469","WW2 A 193 (-3.8A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None;None","1.14A","4ey7B-3k9bA:46.7","4ey7B-3k9bA:36.13"],["4EY7_B_E20B605_1","ACETYLCHOLINESTERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1142;GLU A1220;SER A1221;HIS A1468;GLY A1469","WW2 A 193 (-3.4A);WW2 A 193 ( 4.2A);WW2 A 193 (-1.4A);None;None","0.69A","4ey7B-3k9bA:46.7","4ey7B-3k9bA:36.13"],["4FGL_A_CLQA303_0","RIBOSYLDIHYDRONICOTINAMIDE DEHYDROGENASE [QUINONE]","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1209;GLY A1210;VAL A1047;PHE A1050;ILE A1121","None","1.26A","4fglA-3k9bA:2.5;4fglB-3k9bA:2.4","4fglA-3k9bA:19.96;4fglB-3k9bA:19.96"],["4PTJ_A_FOLA201_1","DIHYDROFOLATE REDUCTASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1260;LYS A1257;LEU A1319","None","1.05A","4ptjA-3k9bA:1.4","4ptjA-3k9bA:14.69"],["4TWD_C_377C401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TYR A1152;ASN A1103;GLU A1246;LEU A1157","None","1.01A","4twdB-3k9bA:undetectable;4twdC-3k9bA:undetectable","4twdB-3k9bA:19.89;4twdC-3k9bA:19.89"],["4TWD_E_377E401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TYR A1152;ASN A1103;GLU A1246;LEU A1157","None","0.98A","4twdD-3k9bA:undetectable;4twdE-3k9bA:undetectable","4twdD-3k9bA:19.89;4twdE-3k9bA:19.89"],["4TWD_J_377J401_1","CYS-LOOP LIGAND-GATED ION CHANNEL;CYS-LOOP LIGAND-GATED ION CHANNEL","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"TYR A1152;ASN A1103;GLU A1246;LEU A1157","None","0.93A","4twdI-3k9bA:undetectable;4twdJ-3k9bA:undetectable","4twdI-3k9bA:19.89;4twdJ-3k9bA:19.89"],["4WNU_C_QDNC602_1","CYTOCHROME P450 2D6","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"LEU A1230;GLY A1223;GLU A1225;ALA A1243;SER A1245","None","1.12A","4wnuC-3k9bA:undetectable","4wnuC-3k9bA:22.89"],["4XLD_A_BRLA502_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"PHE A1101;GLY A1147;LEU A1255;HIS A1468;LEU A1363","None;None;None;None;WW2 A 193 (-3.8A)","1.40A","4xldA-3k9bA:undetectable","4xldA-3k9bA:19.41"],["4ZJQ_D_ERYD1101_0","MULTIDRUG EFFLUX PUMP SUBUNIT ACRB","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"THR A1321;SER A1228;MET A1446;ILE A1350;GLU A1333","None","1.45A","4zjqD-3k9bA:undetectable","4zjqD-3k9bA:20.26"],["5HBS_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"LEU A1110;LEU A1051;THR A1167;TYR A1152","None","1.03A","5hbsA-3k9bA:undetectable","5hbsA-3k9bA:13.09"],["5JGL_B_SAMB301_1","UBIE\/COQ5 FAMILY METHYLTRANSFERASE, PUTATIVE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"ASP A1027;ASN A1204;PHE A1076","None","0.76A","5jglB-3k9bA:undetectable","5jglB-3k9bA:20.63"],["5KQS_A_SAMA307_0","GENOME POLYPROTEIN","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1248;GLY A1143;GLY A1141;GLY A1224;ASP A1090","None;WW2 A 193 (-3.4A);WW2 A 193 (-3.8A);None;None","0.89A","5kqsA-3k9bA:undetectable","5kqsA-3k9bA:20.08"],["5M5B_A_SAMA1001_0","NS5 METHYLTRANSFERASE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"GLY A1248;GLY A1143;GLY A1141;GLY A1224;ASP A1090","None;WW2 A 193 (-3.4A);WW2 A 193 (-3.8A);None;None","0.89A","5m5bA-3k9bA:undetectable","5m5bA-3k9bA:19.81"],["5NWV_A_ACAA18_1","SCRFP-TAG,GP41","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",5,"SER A1113;LYS A1111;GLU A1296;LEU A1295;GLU A1114","None","1.33A","5nwvA-3k9bA:undetectable","5nwvA-3k9bA:7.81"],["5XIP_A_HFGA1003_1","PROLYL-TRNA SYNTHETASE, PUTATIVE","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",3,"GLU A1471;TRP A1138;HIS A1468","None","1.07A","5xipA-3k9bA:undetectable","5xipA-3k9bA:21.83"],["6JI6_A_ACTA305_0","GLUTATHIONE S-TRANSFERASE CLASS-MU 26 KDA ISOZYME","3k9b","LIVER CARBOXYLESTERASE 1","Homo sapiens",4,"GLY A1052;LEU A1051;SER A1150;GLN A1169","None","1.14A","6ji6A-3k9bA:undetectable","6ji6A-3k9bA:17.92"]]